UPDATE: Helus Pharma (HELP) - A Permanent CEO, a Clean DDI Study, and 11 Million New Shares

Q1 FY2027 delivers the Intra-Cellular hire I wanted and the drug-interaction data the adjunctive thesis needed — while the share count quietly climbed from 62M to 73M and the stock ripped +48%